135 related articles for article (PubMed ID: 37206591)
1. Molecular regulatory mechanism of LILRB4 in the immune response.
Liu H; Yang J; Zhang J; Zhang P; Zhang M; Yang C; Liu L; Huang C; Wang W; Zhai Y; Yang J
Cent Eur J Immunol; 2023; 48(1):43-47. PubMed ID: 37206591
[TBL] [Abstract][Full Text] [Related]
2. LILRB4, from the immune system to the disease target.
Liu J; Wu Q; Shi J; Guo W; Jiang X; Zhou B; Ren C
Am J Transl Res; 2020; 12(7):3149-3166. PubMed ID: 32774691
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.
Katz HR
Immunol Rev; 2007 Jun; 217():222-30. PubMed ID: 17498062
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases.
Lu HK; Rentero C; Raftery MJ; Borges L; Bryant K; Tedla N
J Biol Chem; 2009 Dec; 284(50):34839-48. PubMed ID: 19833736
[TBL] [Abstract][Full Text] [Related]
5. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Xiang Z; Yin X; Wei L; Peng M; Zhu Q; Lu X; Guo J; Zhang J; Li X; Zou Y
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397424
[TBL] [Abstract][Full Text] [Related]
6. LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells.
Li Z; Deng M; Huang F; Jin C; Sun S; Chen H; Liu X; He L; Sadek AH; Zhang CC
Cell Mol Immunol; 2020 Mar; 17(3):272-282. PubMed ID: 31700117
[TBL] [Abstract][Full Text] [Related]
7. Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5.
Truong AD; Hong Y; Tran HTT; Dang HV; Nguyen VK; Pham TT; Lillehoj HS; Hong YH
Poult Sci; 2019 Dec; 98(12):6989-7002. PubMed ID: 31376355
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
[TBL] [Abstract][Full Text] [Related]
10. LILRB4, an immune checkpoint on myeloid cells.
Yang T; Qian Y; Liang X; Wu J; Zou M; Deng M
Blood Sci; 2022 Apr; 4(2):49-56. PubMed ID: 35957669
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
12. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory leukocyte immunoglobulin-like receptors in cancer development.
Zhang F; Zheng J; Kang X; Deng M; Lu Z; Kim J; Zhang C
Sci China Life Sci; 2015 Dec; 58(12):1216-25. PubMed ID: 26566804
[TBL] [Abstract][Full Text] [Related]
14. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
15. A dual positive and negative regulation of monocyte activation by leukocyte Ig-like receptor B4 depends on the position of the tyrosine residues in its ITIMs.
Park M; Liu RW; An H; Geczy CL; Thomas PS; Tedla N
Innate Immun; 2017 May; 23(4):381-391. PubMed ID: 28409541
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.
Barrow AD; Astoul E; Floto A; Brooke G; Relou IA; Jennings NS; Smith KG; Ouwehand W; Farndale RW; Alexander DR; Trowsdale J
J Immunol; 2004 May; 172(10):5838-42. PubMed ID: 15128762
[TBL] [Abstract][Full Text] [Related]
18. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.
Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK
Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871
[TBL] [Abstract][Full Text] [Related]
19. Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells.
Chen J; Wang H; Xu WP; Wei SS; Li HJ; Mei YQ; Li YG; Wang YP
Oncotarget; 2016 Aug; 7(35):56129-56146. PubMed ID: 27276708
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte immunoglobulin-like receptor B4 deficiency exacerbates acute lung injury via NF-κB signaling in bone marrow-derived macrophages.
Qiu T; Zhou J; Wang T; Chen Z; Ma X; Zhang L; Zou J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
